SK bioscience Co.,Ltd. (KRX:302440)
South Korea
· Delayed Price · Currency is KRW 54,000
-400 (-0.74%)
At close: Dec 5, 2025
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 4.23 trillion as of December 5, 2025. Its market cap has increased by 6.33% in one year.
Market Cap
4.23T
Enterprise Value
3.88T
Revenue
624.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
54,000.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 4.23T, a decrease of -67.27%. That is a compound annual growth rate of -21.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4,231.93B | 7.17% |
| Dec 30, 2024 | 3,948.70B | -28.57% |
| Dec 28, 2023 | 5,528.45B | -2.04% |
| Dec 29, 2022 | 5,643.63B | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 39.95T |
| ALTEOGEN | 27.76T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8,911.91B |
| LigaChem Biosciences | 7,139.05B |
| Peptron | 6,668.76B |